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Synopsis
Obesity in older adults impacts not only morbidity and mortality, but importantly impacts quality 
of life and the risk of institutionalization. Weight loss interventions can effectively lead to 
improved physical function. Diet-alone interventions can detrimentally impact muscle and bone 
physiology and without interventions to affect these elements, can lead to adverse outcomes. 
Understanding social and nutritional issues facing older adults is of utmost importance to the 
primary care provider. The insufficient evidence related to pharmacotherapy is discussed as well as 
an overview of using physiologic rather than chronologic age is addressed for identifying suitable 
candidates for bariatric surgery.
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Epidemiology of Aging & Obesity
By the year 2030 in the United States, over 20% of the population will be over the age of 65 
years1 (Figure 1), up from 15% of the population today2. The fastest growing demographic 
are the ‘oldest old’, individuals aged over 85 years. Much of the demographic shift is due to 
the emergence of baby boomers, adults born mid-1946 to mid-1964, into older adulthood 
(aged ≥65 years). Improvements in medical care, chronic disease management and infection 
control over the past century has also led to increases in life expectancy3,4. Based on recent 
census data, life expectancy at age 65 is now 82.8 years in males and 85.3 years in females5. 
The demographic changes observed during the aging process leads to a trajectory of 
disability6, independent of other influencing comorbidities. For instance, individuals 
surviving into old age are at risk of functional impairments – inability to transfer, walk, 
dress, eat, toilet, and bathe7 – which subsequently lead a loss of independence, impairment 
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in quality of life and institutionalization8–10. Individuals are exposed to a longer period of 
time in which they may develop comorbidities and be at risk for developing incident 
disability11.
The obesity epidemic is not unique to a middle-age or a pediatric population. The prevalence 
of obesity in older adults, classified using body mass index (BMI), continues to rise over 
time. Recent estimates from the National Health and Nutrition Examination Surveys 
demonstrate that adults over age 60 have obesity rates exceeding 37.5% in males and 39.4% 
in females12 (Figure 2). These estimates have been replicated and are increasing in other 
developed countries as well, including the United Kingdom13 and Canada14.
Defining Obesity in Older Adults
Body composition changes with ageing. Throughout adulthood, a natural increase in body 
fat develops up to the 8th decade of life, after which there is a reduction15. Redistribution of 
fat from peripheral and subcutaneous sources to a central location leads to increased waist 
circumference and waist-hip ratio in older adults. Importantly, there is a natural loss of 
muscle mass and strength with aging, termed sarcopenia16. Sarcopenia can also be 
accelerated in other processes including deconditioning, immobility or other acute 
illnesses17–19. Muscle mass and strength is believed to be vitally important in the 
preservation of physical function and independence in this population20. Using standard 
adult classifications for weight status, such as BMI, may thus underestimate adiposity for a 
given individual.
Many epidemiological and intervention-based studies have used BMI as a surrogate for 
adiposity. Standard BMI categories are used ubiquitously in clinical practice and are based 
on the World Health Organization cut-points of underweight (BMI<18.5kg/m2), normal 
weight (18.5–24.9), overweight (25–29.9), and obese (30+). BMI is easy to use, cheap and 
can be measured using a simple stadiometer and a weight scale; however, BMI is a poor 
measure of adiposity in older adults. First, individuals lose height as they age. The Baltimore 
Longitudinal Study of Aging noted that both males and females lost height with age21 which 
impacts the BMI’s denominator, possibly leading to an overestimation of its overall value in 
this population. Second, while BMI is clearly valuable as a population-level measure, it has 
poor diagnostic accuracy for identifying older adults with obesity22,2324. Using data from 
the 1999–2004 National Health and Nutrition Examination Survey, the sensitivity of BMI in 
accurately identifying adiposity was 32.9% in males and 38.5% in females. Third, as 
previously described, older adults tend to gain weight in central regions of their body. BMI 
fails to distinguish between peripheral and visceral obesity, an important consideration in 
individuals who are classified as having normal weight central obesity25. Based solely on 
BMI, this category of individuals would often not be a target for obesity therapy because 
they fall within the normal range (BMI of 18.5–24.9kg/m2). Individuals with central obesity 
presenting with a normal BMI may also be at risk for adverse cardiometabolic dysfunction 
including dyslipidemia, coronary disease, hypertension, and early mortality26–28. One large 
scale epidemiological study using 15,184 adults aged 18–90 years with normal BMI and 
central adiposity based on waist-to-hip ratio29 found that individuals with normal weight 
central obesity had a higher risk of total and cardiovascular mortality (HR of 1.87 
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[1.53,2.29] in males and 1.48 [1.35,1.62] in females). These relationships have been 
observed in older adults as well, whereby women have higher short-term cardiovascular 
mortality than males, and males have higher long-term cardiovascular mortality than 
females27. Irrespective of sex, individuals with normal weight central obesity (waist-hip 
ratio or waist circumference) are at higher risk of long-term disability28. Identifying and 
evaluating individuals in clinical practice who otherwise may not be identified as high risk is 
needed. Such misclassification can be problematic from a population-based management 
standpoint. Lastly, BMI accounts for both fat-free (muscle) and fat mass, the former of 
which declines during the aging process. This can further lead to misclassification and 
potential underestimation of adiposity and risk.
Unfortunately, gold-standard methods for identifying adiposity with accuracy, including 
magnetic resonance imaging and computer tomography, are non-covered indications in 
clinical practice unless performed for other reasons. Dual-energy absorptiometry is more 
routinely available, but assessment of body composition is not covered by Medicare. 
Bioelectrical impedance can be a crude measure for body composition assessment in older 
adults and portable devices are available; however, the alterations in fluid balance in older 
adults30, along with a higher incidence of prosthetic implants31 and implantable 
cardiovascular devices32 makes this modality less favorable. As such, BMI combined with a 
marker of central adiposity may provide a cost-effective approach to improved diagnostic 
accuracy within a clinical practice.
Established BMI cut-points correspond to adverse disease processes, including mortality33. 
Multiple population-based cohort studies have examined the relationship between obesity 
and premature death. In one study, obesity led to an estimated 111,909 excess deaths34. 
While obesity in mid-life is associated with reduced life-expectancy, the duration of obesity 
has a considerable effect on long-term mortality35, disability36 and nursing home 
placement37 as evidenced in numerous epidemiological studies. The relationship between 
BMI and mortality in populations has been shown to be representative of a “U” shaped 
curve34; individuals classified as underweight and obese are at the extremes with higher 
risks of mortality. With age, the curve flattens and shifts to the right, indicating that standard 
BMI cut-points differ in older adults than in younger populations. A meta-analysis that 
evaluated 32 studies between 1990–2013 (including 197,940 adults aged 65 and over) also 
demonstrated a “U” shaped curve38. Yet, the lowest risk of mortality was observed in those 
with a BMI of ~27.5kg/m2. In fact, the risk of death only increases at a BMI>33.0 (HR 1.08 
[95%CI: 1.00,1.15]).
In select older adult populations, not all participants with elevated BMIs should be 
considered at high risk. An ‘obesity paradox’ exists whereby elevated body weight may be 
protective, mitigating death in select populations. For instance, a nursing home systematic 
review evaluated 19,538 subjects with a BMI≥30kg/m2 and found that the risk of death was 
significantly lower than for the referent (normal BMI) group (HR 0.69 [95% CI:
0.60,0.79];p<0.001)39. A number of factors are thought to explain this: first, issues related to 
the inability of BMI to discern between visceral and subcutaneous fat; second, 
cardiovascular fitness likely moderates the relationship between obesity and death. 
Individuals with high levels of cardiovascular fitness irrespective of their obesity 
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classification portend to better outcomes40; third, excess adiposity in high risk populations at 
risk for frailty, itself a predictor of death, may be protective. Populations such as 
hemodialysis patients, congestive heart failure, or nursing home residents all tend to lose 
weight (consisting of both fat and muscle) with aging which promotes wasting, cachexia and 
mortality41. Fourth, there may be self-selection—individuals with excess adiposity who have 
survived to old age may have a survival advantage as compared to those who have died 
earlier in life. As such, practitioners should be made aware of these considerations in select 
populations, particularly when using BMI as a measure for adiposity in older adults with 
these specific co-morbidities.
Impact of Obesity on Physical Function/Disability
Overweight and obesity predisposes to disability and decreased physical functioning. Using 
the Health, Aging and Body Composition data, adults classified as overweight or with 
obesity using BMI at ages 25, 50 and 70–79 years had a HR 2.38 of incident disability over 
a 7 year period35. Similar relationships have been observed using either waist circumference 
or body fat percent, both in males and females. A systematic review by Schaap et al42 
demonstrated that adults with a BMI≥30kg/m2 aged 65years and older had a 60% higher risk 
of incident disability (95%CI:1.43,1.80). A “U” shaped relationship is also observed 
between BMI and nursing home admission from community-dwelling adults43. 
Longitudinally, there appears to be a relationship. As the obesity epidemic has emerged in 
the past few decades, recent evidence suggests that its relationship with disability continues 
to be problematic, yet may be leveling off44. A recent study evaluated three consecutive time 
periods using National Health and Nutrition Examination Surveys (1988–1994, 1999–2004, 
and 2005–2012) and evaluated the association between obesity and disability. The 
population attributable fraction for obesity having a functional impairment and severe ADL 
impairment was 23.2% (95%CI: 20.5,25.7) and 24.6% (95%CI: 12.3,35.2), respectively, in 
individuals aged 60 years and older. Individuals classified as having obesity were still at 
much higher risk of limitations, yet limited wave-to-wave variability was observed. Other 
measures of adiposity, including body fat percent and waist circumference have also been 
associated with impaired physical function and disability and parallel these estimates. A 
study evaluating the cross-sectional association between obesity using body fat and 
disability demonstrated a significant odds of disability45,46. While there are challenges in the 
diagnostic accuracy of obesity, irrespective of the body composition or anthropometric 
measure used, in community dwelling adults, obesity is associated with a poorer prognosis 
of physical function.
Obesity is also associated with increased risk of falling in older adults. Over one-third of 
adults aged 65 years and older fall each year47, making it necessary to screen for fall risk in 
the primary care setting48,49. Two studies using Health and Retirement Study 1998–200650, 
and the Behavioral Risk Factor Surveillance System 2014 data51, demonstrated the degree of 
obesity (class I vs. II vs. III) was associated with a higher risk of falling. Using the Health 
and Retirement Study data, those with class III obesity (BMI>35kg/m2 have a OR 1.50 
[1.21–1.86] of falling, while estimates from the Behavioral Risk Factor Surveillance System 
are slightly lower (1.23 [1.13,1.35] in females; 1.18 [1.06,1.32] in males]. While fall risk is 
increased, risk of hip fractures from obesity is lower in this population52. Evaluating 
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individuals who are at risk can prevent falls that may otherwise lead to restriction of social 
function, fractures and death48,50.
Sarcopenic Obesity – a subset of high-risk individuals
Sarcopenia in individuals with obesity is a subgroup that deserves specific attention. 
Sarcopenia is derived from the Greek word, “sarcos” meaning flesh and “penia” meaning 
lack of. Infiltration of fat occurs within muscle tissue that can lead to impairments in muscle 
physiological parameters53,54. The definition of sarcopenia and obesity (sarcopenic obesity) 
continues to be fraught with methodological challenges55 and discrepancies in defining 
sarcopenia (muscle mass vs. muscle strength) and obesity (body fat vs waist circumference 
vs BMI). Nonetheless, such individuals are at considerably higher risk than those with either 
of the two conditions independently. While the medical definition has evolved over the past 
three decades55, based on the 2014 Foundations for the National Institutes of Health 
Conference20, sarcopenia is simply the loss of muscle mass and function with aging. 
Specific cut-points have been developed for use. While several earlier studies focused on 
loss of muscle mass as the key determinant of sarcopenia56, emerging evidence suggests that 
muscle strength may be a more powerful determinant of incident disability57.
The development of sarcopenia in old age is a natural phenomenon that can be partially 
mitigated with lifestyle interventions altering the threshold at which disability ensues16,58. 
Short- and long-term changes of both muscle mass and strength occur. Yet, changes in 
strength may occur without corresponding changes in muscle mass as observed in an earlier 
study using Health, Aging, Body Composition data59. Earlier work using the New Mexico 
Aging study demonstrated that individuals with sarcopenic obesity had a HR 2.63 [95%CI: 
1.19–5.85] of developing an impairment of their instrumental activities of daily living over 
the course of a 8 year period60. This study defined sarcopenic obesity using appendicular 
skeletal muscle mass and body fat cutpoints61. Data from the InChianti study demonstrated 
that individuals with low muscle strength and obesity (based on knee extensor strength and 
BMI) had lower walking speeds than their counterparts over a 6-year period of time62. Much 
of our own work has revolved around using dual x-ray absorptiometry-defined muscle mass 
with the FNIH cutpoints with body-fat defined obesity (men>25%, females>35%), 
suggesting a significant relationship with limitations63 and mortality64. Mortality is less 
clear as demonstrated using NHANES III data65 (using BIA-defined muscle mass) and 
NHANES 1999–2004 data (using dual x-ray absorptiometry-defined muscle mass)64. 
Impaired muscle strength in conjunction with obesity, irrespective of its definition, is 
associated in crosssectional and longitudinal studies with adverse and negative outcomes, 
more so than muscle mass42. Thus, the importance of identifying patients with both 
sarcopenia and obesity is of paramount importance.
Evidence for Weight Loss in Older Adults?
Previous epidemiologic studies have provided conflicting findings on outcomes following 
weight loss in older adults; however, these studies failed to differentiate between intentional 
vs. unintentional weight loss and do not account for important confounding variables and 
reverse causality66,67. A joint consensus statement, published in 2005 by members of The 
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Obesity Society, American Society of Nutrition and The National Association for the Study 
of Obesity, provided some evidence on managing this disease in older adults,68 and several 
randomized controlled trials have since been published demonstrating the benefits and the 
harms of weight loss in older adults69. (Note that we define ‘weight loss’ as intentional in 
the section below.)
A healthy lifestyle has been shown to compress the number of years of disability, according 
to data from the Cardiovascular Health Study 1989–201570. Monitoring multiple lifestyle 
factors, including physical activity, diet, and BMI, 5,248 community adults aged 65 years 
and older who were not wheelchair dependent were identified. Activities of Daily Living 
were assessed and the ratio of the number of years living without any disability to the total 
number of years lived was ascertained to indicate compression or expansion of the disabling 
period. Obesity was associated with a decrease of 7.3% (95%CI: 5.4–9.2) as compared to 
normal weight individuals. The lowest quintile of the Alternative Healthy Eating Index was 
associated with a 3.7% (95% CI: 1.6–5.9) lower score than the highest quintile. Yet, 
engaging in physical activity demonstrated that for every 25 blocks walked in a week, 0.5% 
(95% CI: 0.3–0.8) higher proportion of years was gained disability-free. The article 
concluded that healthy lifestyles can compress the duration of disability in a person’s 
remaining lifetime.
A recent qualitative systematic review evaluated six randomized controlled trials from 2005–
2015 in adults aged 60 and older (mean age >65 years)69. Obesity was defined as 
BMI≥30kg/m2 or waist circumference ≥88cm/102cm in females/males respectively. Of 
5,741 citations, 19 trials were identified, of which 6 were unique cohorts. Results suggested 
that a dietary weight reduction program combined with a physical activity program (aerobic 
and resistance) improved physical performance and quality of life and lowered the risk of 
reduced muscle mass, strength and bone loss. Weight loss ranged from 0.5 to 10.7kg. A 
recently published randomized trial with 141 participants, demonstrated that weight loss 
inclusive of both aerobic and resistance exercises led to improvements in the physical 
performance test, peak oxygen consumption, and muscle strength, despite only marginal 
reductions in lean muscle mass71. Additionally, there was no difference in exercise-related 
adverse events. In a separate review, weight loss in older adults with obesity was associated 
with reduced risk of death72. The authors identified 15 randomized controlled trials 
including 17,186 participants with a mean age of 52 years at randomization. The mean BMI 
was 30–46 kg/m2 with an average follow-up period of 27 months (ranging from 18 months 
to 12.6 years). The weight loss group experienced a 15% lower all-cause mortality risk 
(relative risk 0.85 [95% CI:0.73,1.00]). While further evidence is needed to ascertain the 
impact on long-term mortality, weight loss appears safe and effective in older adults with 
obesity.
Cautions of Losing Weight in Older Adults
There are important risks that often get overlooked in this population by practitioners. Loss 
of weight leads not only to loss of fat mass, but also to loss of muscle mass, thereby 
promoting sarcopenia and its ensuing adverse outcomes73. The general principle that each 
pound lost equates to 75% fat and 25% muscle has been debated but is generally accepted74. 
Batsis and Zagaria Page 6
Med Clin North Am. Author manuscript; available in PMC 2019 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Moreover, loss of weight impacts bone metabolism and turnover promoting 
osteoporosis75–77.
Although sarcopenia is a natural phenomenon of the aging process, its acceleration with 
weight loss efforts is of considerable concern. Diet or diet and exercise-induced weight loss 
induces hormonal changes that negatively impact muscle mass and strength and is 
exacerbated by moderate caloric restriction. A review of 33 interventions demonstrated 
significant decreases from baseline in knee extensor strength (−7.5%) and handgrip strength 
(−4.6%) following diet-induced weight loss with moderate energy restriction76. Failure to 
engage patients in isokinetic resistance exercises will lead to likely loss of muscle mass and 
strength and reduce the impact of the gains in function individuals may otherwise attain with 
weight loss78.
A number of randomized controlled trials have demonstrated that caloric restriction alone 
leads to loss of bone mineral density (BMD). Villareal’s group demonstrated that a loss of 
hip BMD was attenuated, in part, when resistance exercise was coupled with a weight loss 
program, preventing an increase in bone turnover58,71. In another study, a meta-analysis of 
32 randomized controlled trials, weight loss had no significant effect on total BMD75. 
However, the pooled study data suggested that hip and lumbar spine BMD were significantly 
lower after 4 months, particularly in adults who were classified as having obesity. Lumbar 
spine BMD was also lower after calorie restriction in interventions longer than 13 months. 
While these results were in adults age 50 years and older, their sensitivity analysis stratified 
by age revealed that hip BMD loss was highest in adults age 65 and older. This finding has 
considerable implications for the older adult who is at risk of falling. Approximately 30% of 
falls among older adults result in injury, 10% of which are fractures79. Hip fractures are 
especially devastating in this population and portend considerable morbidity and mortality80.
Generally, obesity in the older adult population is safe and effective and can lead to 
considerable improvements in cardiometabolic risk and physical function. While there are 
important known risks associated with weight-loss in this population, they likely can be 
mitigated with appropriate health promotion interventions. As with all patients in a geriatrics 
practice, practitioners need to manage the benefits vs. the risks of any interventions, and in 
select individuals, weight loss should be encouraged.
Obesity in the Primary Care Setting
Obesity prevention efforts should be based in primary care settings, where front-line 
clinicians have longitudinal relationships to provide brief, motivational interviewing to 
engage patients in behavioral change. Intensive behavioral counseling can induce clinically 
meaningful weight loss of between 0.3–6.6kg, but little research is available on primary care 
practitioners providing this care. A systematic review suggested that different 
interventionists can deliver counseling, both in person or by telephone in this setting81. An 
additional review suggested that a multidisciplinary team approach consisting of 
collaborative care was much more effective82. This review conflicts with a recent two-arm 
randomized trial of 2,728 patients that demonstrated that a behaviorally informed, very brief 
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(30 second) physician-delivered opportunistic intervention was acceptable and effective to 
reduce population mean weight (1.43kg [95% CI: 0.89,1.97])83.
In 2011, in the United States, the Centers for Medicare and Medicaid Services began 
reimbursing obesity counseling (current procedural terminology code G0447) for clinicians 
in a primary care setting to provide 22 targeted,15-minute intensive behavioral therapy 
counseling in a continuous 12-month period84. The goal was to achieve a mean weight loss 
of 3kg in beneficiaries whose BMI was ≥30kg/m2. Practice management barriers85 exist in 
implementing this benefits, although novel technologies86 may be helpful in addressing 
these issues. In 2012, the first full year of data, 27,338 (0.1%) of Medicare beneficiaries over 
age 65 availed of the benefit87. This increased slightly in 2013 to 46,821 (0.17%). The 
estimated proportion of persons with obesity using the benefit increased from 0.35% to 
0.60%, with a mean of 1.99 and 2.16 claims/user. This data suggests its low uptake may not 
only be due to poor implementation patterns, but other support staff such as health coaches 
and dieticians should be integrating in delivering this important service. Novel delivery 
modalities to engage patients may be a strong consideration moving forward that include 
transition to value-based care models or increased reimbursements.
Medical Evaluation Specific to Older Adults with Obesity
The nutritional needs and caloric intake for healthy older adults is known to decrease with 
age in both sexes. The caloric difference between early adulthood and older adulthood 
ranges between 300–500 kCal/day. Much of this is due to age-related phenomena related to 
basal metabolic rate which drops considerably with age88. The following section will discuss 
specific concerns that a primary care provider should consider using a ‘geriatric specific’ 
approach, as compared to a middle aged adult with obesity89.
Communication in clinical settings with older adults requires careful communication 
strategies that are often overlooked by clinicians. Behavioral techniques must be adapted to 
accommodate not only the sensory deficits the older adult faces such as hearing and vision, 
but need to be adapted to changes in cognition and executive function90, and their preference 
for shared-decision making91. Others have noted of a ‘gap’ between intentions and 
behavioral change92, which itself can be predicted by measures of executive function93. An 
inability to implement intentions will lead to poor execution of the desired change94. Older 
adults may also be better focused on single health behavior change interventions as 
compared to multiple95, focusing on a specific content. These approaches are less confusing 
and can be understood much more adequately. On the contrary, though, complex conditions 
in older adults require multiple strategies to deliver health promotion efforts which can be 
challenging to the clinician. Engaging individuals in strategies to improve self-efficacy 
through social support and change can be helpful to provide information to set goals, engage 
in change, and to promote self-monitoring96. Researchers continue to caution clinicians in 
applying behavioral change principles to older adults as they may require adaptation from a 
younger population.
While primary care providers care for older adults, the lack of specific geriatric training can 
be problematic in delivering behavioral change interventions. First, motivational 
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interviewing, a core tenant in eliciting change and in the Medicare Obesity Benefit is heavily 
influenced by the contextual aspects of delivery and by the clinician97 – internists may 
approach elements differently than geriatricians. Second, geropsychological principles are 
often not integrated in routine interventions98. This includes social participation which is 
strongly related to better health and can lead to forming new goals in one’s life99. This 
allows for a reframing of the discussion to engaging in change. Third, goals in seniors are 
different, in part due to multimorbidity100, but also due to the changing perceptions on aging 
and health101–104. Fourth, aging individuals have limited lifespans and, hence, patients focus 
more on the present day than the future. These elements lead to significant challenges in a 
busy primary care setting.
A thorough medical evaluation is needed in older patients that wish to improve their health 
and physical function through weight loss. The primary care clinician (or obesity medicine 
specialist) should identify whether there are any recent changes in health status (medical or 
economic). Recent hospitalizations and changes in functional status (e.g. joint replacement 
leading to physical inactivity) that may lead to weight gain105. Other standard questioning 
on weight history, previous strategies and alcohol use parallel methods used in the general 
population. Notably, we highlight two main concerns specific to older adults including 
medications and social support.
The number of medications prescribed increases with age and with the number of chronic 
conditions. Polypharmacy is a significant risk in older adults as it is associated with 
increased risk of cognitive impairment, urinary incontinence, falls and declines in physical 
function106. The American Geriatric Society has developed the Beers Criteria107, which 
clearly identifies potentially inappropriate medications in older adults and assists healthcare 
providers in improving medication safety for this population. Its purpose is to inform 
clinical-decision-making concerning the prescribing of medications for older adults in order 
to improve safety and quality of care. There are a number of medications that are considered 
‘obesogenic’ that should be re-evaluated as part of the evaluation. As older adults have a 
higher incidence of diabetes108, depression109, pain110 and hypertension111, medications 
treating these chronic diseases may increase the risk of a person gaining weight. 
Additionally, a number of these medications are listed on the Beer’s criteria. The primary 
care practitioner, in concert with a clinical pharmacist on the multidisciplinary team can 
assist in streamlining not only the number of medications, but also the class of medications 
that promote weight gain. Table 1 briefly highlights some of the commons medications that 
predispose to weight gain.
Socioeconomic and ethnic disparities are two specific social determinants of health that 
increasingly are being recognized as important predictors in obesity management and 
adverse health. An elder on a fixed income (often a social security income) and must make 
choices between their food consumption and other care needs. Food insecurity is defined as 
the limited or uncertain availability of nutritional adequate and safe foods, or the limited or 
uncertain ability to acquire acceptable foods in socially acceptable ways112. Food insecure 
older adults individuals have poorer dietary intake, nutritional status and health status than 
food secure older adults113. Simple questions that should be asked include:
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• Where is your food coming from?
• Who purchases your food?
• Do you have to pay for your medical bills and scrimp on food?
Such questions are helpful in that it leads to information on affordability of food. A true 
multidisciplinary team led by the physician that embodies a dietician, social worker and care 
manager can be helpful in intervening in this population. A dietician is of utmost importance 
in that they are able to perform, not only the usual functions of evaluation and counseling, 
but can assist this population in engage in substituting choices that they can afford.
Most established trials have evaluated calorie-restricted diets ranging from 500–750 
kCal/day under the guidance of a registered dietician69. In older adults, there is ample 
evidence that diets such as the Dietary Approaches to Stop Hypertension114 or the 
Mediterranean diet115 have demonstrated improvements in metabolic parameters, weight 
loss, long-term disability, mortality and cognition. Very low energy or protein sparing diets 
should be avoided in older adults due to risks of dramatic fluid and electrolyte shifts and 
proportionally can lead to augmented muscle mass loss. Villareal, in his studies, proposed a 
loss of ~10% of baseline weight at six months58,71. Supplemental vitamin D of ~800–
1000units and 1200mg of calcium should be considered. The latter can be from dietary or 
supplement sources, although we emphasize the consumption from dietary calcium if at all 
possible considering the recent controversies. Protein intake should also be augmented in 
older adults. Recommended dietary allowance is 1.0g/kg/day, yet since older adults produce 
less protein than younger persons, this should be revised to 1.0–1.2g/kg/day116. Also, a 
larger amount of protein is required to produce an equal response116. Notably, a recent 
Cochrane review demonstrated that protein supplements did not lead to improved 
outcomes117. Early pilot studies during weight loss interventions suggest improved short 
performance physical battery measures. The MeasureUP118 in 67 subjects demonstrated, at 
6-months, a −8.7±7.4kg and −7.5±6.2kg weight loss in the protein and control groups, 
respectively. The authors observed improvements in physical function based on the short 
physical performance battery of +2.4±1.7units and +0.9±1.7 units, respectively (p=0.02). 
Future studies should determine the amount of protein intake, the type of protein (meat vs. 
plant-based) and whether advised supplements for the treatment of sarcopenia (whey, 
leucine carnitine) can augment physical function and further mitigate sarcopenia.
Primary care providers have little training in counseling on physical activity119. They can, 
however, provide targeted information on exercise prescriptions. Such prescriptions should 
be individually tailored based on the individual’s functional status and capacity. The 
American College of Sports Medicine suggest at least 150 minutes of low to moderate 
intensity aerobic activity in all patients, including older adults120. Seniors who may not have 
sufficient cardiovascular fitness may subdivide this time period into smaller increments to 
not only build their endurance but assist in ongoing behavioral change. The practitioner and 
their team can encourage patients to slowly increase their capacity to do so. During weight 
loss efforts, resistance exercises are of paramount importance for the prevention of 
sarcopenia. All individuals should engage in flexibility, balance, and strengthening activities 
with resistance bands or weights that can be free or be attached to wrists or legs. In those 
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with financial difficulties, we advise individuals to utilize common household items (i.e. 
soup cans or jugs of milk). The weekly goals are 2–3 days, with at least 48 hours rest 
between sessions. Each of these sessions should last between 30–40minutes, rotating muscle 
groups and exercises, with 10–12 repetitions for each sessions. Fatigue normally occurs 
between 8–12 repetitions and a bit of fatigue is advisable, but it is important to prevent 
injuries by starting low and going slow, starting with 1–2 pounds or with the lowest 
resistance color band. Physical therapists can assess a person’s 1-repetition maximum and 
advise advancement. We advocate that current multidisciplinary physical activity programs 
should be based on the Life Study121, a multi-center randomized controlled study that 
demonstrated reduced disability over a mean 2.6 year follow-up in 818 patients. Compared 
to a self-instructed exercise program, participants in this structured program demonstrated a 
28% reduction in incident major mobility disability (95% CI:0.57,0.91). These materials are 
freely available on <https://www.thelifestudy.org>. Additionally, the National Institute on 
Aging has a booklet of exercises that can be accessed and downloaded at <https://
www.nia.nih.gov/health/publication/exercise-physical-activity/introduction>, free of charge 
for clinicians and patients to engage at home.
Clinicians can play a paramount role in the monitoring of their older patients undergoing 
weight loss. While there is no firm evidence pertaining to monitoring parameters, we 
recommend the following. First, consideration should be given to assess baseline bone 
density during such efforts. Medicare indications for women are quite broad (ie: post-
menopausal) yet those for men may be slightly more challenging to find. The United States 
Preventive Services Task Force recommendations for osteoporosis screening in men do not 
provide a firm statement and conclude that the evidence is insufficient to assess the balance 
of benefits and harms of screening122. Some potential indications in men include: x-ray 
evidence of possible osteopenia, osteoporosis or vertebral fractures; a person taking steroids; 
hyperparathyroidism; monitoring if osteoporosis drug therapy is working. Some examples of 
biomarkers of bone turnover that can be considered in the evaluative process, including 
osteocalcin, type I procollagen, urine collagen type-1 cross-linked N-telopeptide. These may 
help direct the impact of weight loss on bone turnover. Baseline and longitudinal monitoring 
of grip strength is an office procedure that can be easily integrated in any busy practice. The 
recent approval of an ICD-10 code for sarcopenia may allow for further screening and 
routine integration in practice. Last, monitoring of vitamin D levels may be helpful. 
Different societies have different views on monitoring of levels49. Our practice is to assess 
baseline Vitamin D levels during routine weight loss management. As with any intervention 
in older adults, risks vs. benefits of monitoring is needed, and further studies should best 
inform the appropriate indices clinicians should considering during such efforts.
Pharmacotherapy
With the emergence of newer medications effective in weight management, older adults are 
increasingly asking about the possibility of taking such medications. The AACE/ACE 
guidelines explicitly state that there is insufficient evidence to recommend weight-loss 
medications in older adults123. As is the case with most pharmaceutical-based clinical trials, 
to prove efficacy, older adults were excluded from most trials, biasing outcomes towards 
younger patients. Unfortunately, we caution extrapolating such results to older adults whose 
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pharmacokinetics and pharmacodynamics properties differ from those in younger, robust 
populations who often have fewer comorbid conditions and are on fewer medications.
Of the obesity medications available, two trials (phentermine/topiramate and liraglutide) 
have documented efficacy analyses between older adults and younger counterparts. These 
trials enrolled 7% (n=254) and 6.9% (n=232) older adults, respectively, of their study 
subjects123–128. There were no observed differences in efficacy, safety and pharmacokinetics 
between subgroups. The other commercial medications had insufficient study sample to 
make any statistical comparisons. Preliminary data suggest that pharmacokinetic data on 
phentermine/topiramate, liraglutide, lorcaserin or naltrexone/bupropion were no different 
between younger/older. The propensity to add to an older adult’s polypharmacy should not 
be overstated as this leads to medication errors and subsequent adverse drug events, 
increased risk for falls, delirium and costs. Table 2 highlights some of the absolute 
contraindications to these medications and some of the common side effects and major risks 
that older adults may face, irrespective of the lack of evidence. Given the need for obesity 
treatments and the limited data currently available, further research in older adult 
populations is important.
Bariatric Surgery
An effective treatment approved by the NIH in 1991 is bariatric surgery129. This procedure 
has gained considerable popularity and is increasingly being performed in persons with 
obesity who are at high risk of medical complications and/or have co-morbidities. In the 
general population, there is considerable epidemiologic and trial data demonstrating its 
safety, efficacy, and effectiveness130–135. The extent of the safety and efficacy in older adults 
continues to be debated in the surgical literature. Many studies have used varying cut-points 
for older adults (ranging from 50–65 years), and are fraught with considerable 
methodological problems, including reduced study power, study time period bias, and 
inconsistent definitions. Additionally, the evolving surgical and medical care of this patient 
population, and the establishment of high volume Bariatric Surgery Centers of Excellence 
have led to considerably improved outcomes136,137. A number of systematic reviews have 
been published discussing the short- and long-term outcomes of bariatric surgery in an older 
adult population138, and are outside the scope of this particular review.
European guidelines139 have noted that the procedure should be considered in carefully 
selected patients. We previously developed an approach in older adults that highlights 
physiologic as opposed to chronologic age140. A laparoscopic approach is favored as 
compared to an open approach. By applying the principles of a comprehensive geriatric 
assessment on patients evaluated for surgery, the hope is that those carefully selected 
individuals will have improved short- and long-term outcomes. Highlighting the importance 
of future life expectancy, presence of undiagnosed cognitive impairment, medical co-
morbidity that could be impacted by the surgical procedure, and important social support 
mechanisms for the immediate post-operative care are of utmost importance. Previous 
history of post-operative delirium and impairments in vision and hearing are also important 
factors in successful recovery. Understanding such limitations could sway a decision to 
consider surgical intervention or not in a given patient. Being classified as ‘geriatric’ should 
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not preclude evaluation of surgery in those motivated older adults who fulfill many of the 
above noted elements in the geriatric evaluation.
Conclusions
The epidemic of geriatric obesity will continue to impact the role of a primary care provider 
with time. The importance of lifespan prevention measures cannot be overstated to delay the 
onset of disability and impairments in health-related quality of life. Effective lifestyle 
modifications for weight loss can easily be implemented within a busy primary care setting 
to engage individuals. Community-based physical activity interventions are easy, cost-
effective ways to delay disability and enhance physical function. Future studies should focus 
on disseminating and implementing practical ways to integrate established evidence-based 
practices into routine clinical care, without overburdening clinical staff. The use of emerging 
technologies may be helpful adjuncts. Evaluation of pharmacotherapy in this high-risk 
population remains a priority and including older, robust adults may be a reasonable first 
step in evaluating their safety and efficacy. We recommend that bariatric surgery be 
considered for older adults following a comprehensive geriatric assessment and 
interdisciplinary team-based approach is helping in evaluating and engaging these patients in 
this process.
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Key Points
• Older adults with obesity will be an emerging demographic that primary care 
practitioners will need to develop skills in managing.
• Intentional weight loss in this population can be successful and safe.
• Appropriate understanding of the dangers of weight loss on muscle and bone 
are required.
• Pharmacotherapies that are FDA approved for adults have not been 
extensively studied in older adult populations.
• Bariatric surgery can be considered in selective candidates.
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Figure 1. Projected Elderly Population Aged 65 years and older (represented as percentages) in 
the United States based on the 2010 Census and Future Projections
Data from United States Census Bureau. 2010 Census Data. Available at: https://
www.census.gov/2010census/data/. Accessed Jan 20 2013.
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Figure 2. Prevalence of Obesity in ages 60 years and older using National Health and Nutrition 
Examination Surveys over the past 4 decades based on body mass index. Current estimates 
indicate that obesity is present in men in 37.5% and 39.4% in females in the population
Data from Flegal KM, Kruszon-Moran D, Carroll MD, et al. Trends in Obesity Among 
Adults in the United States, 2005 to 2014. JAMA 2016;315(21):2284–2291.
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Table 1
Commonly Prescribed Medications in Older Adults Predisposing to Weight Gain
Disease/Class of Med Examples
Diabetes Insulin, TDZ*, sulfonylureas*
Depression Tricyclics*, SSRIs*
Antipsychotics 1st + 2nd generation*
Neuropathic gabapentin
Antihistamines Diphenhydramine*
Hypertension B-blockers
*
Medications that are listed in the 2015 Beers Criteria107
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Table 2
Relative and Absolute Contraindications to Weight-Loss Medications in Older Adults
Generic Name Absolute Contraindications Side-Effects (>10%) & Major Risks in Older Adults
Locarserin — Renal insufficiency, Tramadol, Heart failure, Serotonin excess, 
hypoglycemia
Phentermine/Topiramate Glaucoma, MAOI hyperthyroidism Constipation headache, xerostomia
Phentermine Glaucoma, Heart failure, CAD, 
Hyperthyroidism, Arrhythmias
Renal insufficiency, Reduced exercise tolerance
Orlistat Malabsorption, cholestasis Fecal urgency, Flatulence, Steatorrhea
Buproprion/naltrexone HTN, Seizures, Hepatic impairment More sensitive to CNS effects, Renal insufficiency, Headache, 
Constipation, N/V
Liraglutide Angioedema, MEN-2, MTC Constipation, Diarrhea, Hypoglycemia, Palpitations, N/V
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